GLP-1 medicines have become increasingly popular for diabetes management and weight loss. Many people assume that all GLP-1 medicines have to be taken as injections. But is that really true?
No. GLP-1 medicines are not limited to injections. While many commonly used GLP-1 medicines are injectable, oral GLP-1 therapy is also available. Oral semaglutide is an important example.
What Are GLP-1 Medicines?
GLP-1 receptor agonists are a group of medicines that mimic the action of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1).
They can help:
- Lower blood glucose levels
- Reduce appetite
- Increase feelings of fullness
- Slow stomach emptying
- Support weight loss in appropriate patients
- Provide additional cardiometabolic benefits in selected people with type 2 diabetes
The 2026 American Diabetes Association Standards of Care recognize GLP-1 receptor agonists as important therapies for people with type 2 diabetes and obesity, with semaglutide and other incretin-based therapies having significant effects on weight and glucose control.
Are All GLP-1 Medicines Injectable?
No.
Many GLP-1 receptor agonists are given by injection, usually under the skin. Examples include injectable semaglutide, liraglutide and dulaglutide.
However, semaglutide is also available as an oral tablet.
The FDA lists Rybelsus (oral semaglutide) as a tablet formulation of a GLP-1 receptor agonist.
Therefore, saying that “GLP-1 medicines are only injections” is an outdated misconception.
Oral vs Injectable GLP-1 Medicines
| Feature | Oral GLP-1 | Injectable GLP-1 |
|---|---|---|
| Route | Tablet | Injection under the skin |
| Example | Oral semaglutide | Injectable semaglutide |
| Frequency | Depends on the medicine | Depends on the medicine |
| Needle required | No | Yes |
| Weight-loss effect | Depends on drug and dose | Depends on drug and dose |
| Diabetes treatment | Yes, for appropriate medicines | Yes |
| Prescription required | Yes | Yes |
The choice between an oral and injectable option depends on the patient’s diabetes, obesity, treatment goals, other medical conditions, tolerability, preferences and the specific medicine available.
Oral Semaglutide: How Is It Taken?
Oral semaglutide has specific administration instructions. It is generally taken on an empty stomach in the morning with a small amount of plain water, followed by a waiting period before eating, drinking other beverages or taking other oral medicines.
This is important because how the tablet is taken can affect its absorption.
Therefore, an oral GLP-1 medicine should not simply be taken like an ordinary tablet.
Why Are Most GLP-1 Medicines Injections?
One reason is that GLP-1-based medicines are peptide-based molecules that can be broken down in the digestive system.
Developing an effective oral formulation is therefore more challenging than developing an injectable formulation.
Special formulations and technologies can allow certain GLP-1 medicines to be administered orally.
Is an Injection Better Than a Tablet?
Not necessarily.
The best treatment is the one that is appropriate for the individual patient.
Some patients prefer tablets because they do not want injections. Others may prefer a once-weekly injection because it may be more convenient than taking a tablet according to specific administration instructions.
The decision should consider:
- Diabetes control
- Body weight and obesity
- Cardiovascular risk
- Kidney function
- Gastrointestinal symptoms
- Other medications
- Treatment goals
- Cost and availability
- Patient preference
Are GLP-1 Medicines Used Only for Diabetes?
No.
Some incretin-based medicines are also approved for chronic weight management in appropriate individuals with overweight or obesity.
However, not every GLP-1 medicine is approved for weight loss, and the indication, dose and formulation can differ between products.
Treatment should therefore be selected according to the patient’s medical condition rather than simply choosing a popular GLP-1 brand.
What About Mounjaro and Tirzepatide?
Tirzepatide, marketed as Mounjaro in many markets, is slightly different from a traditional GLP-1 receptor agonist.
It is a dual GIP and GLP-1 receptor agonist and is administered by subcutaneous injection.
The 2026 ADA Standards distinguish dual GIP/GLP-1 receptor agonists such as tirzepatide from GLP-1 receptor agonists such as semaglutide.
Are GLP-1 Medicines Safe for Everyone?
No medicine is suitable for everyone.
GLP-1-based treatments can cause gastrointestinal side effects such as:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal discomfort
Some patients require slower dose escalation to improve tolerability.
Certain medical conditions may also influence whether these medicines are appropriate. For example, the 2026 ADA Standards advise caution in people with significant gastrointestinal problems and provide specific considerations regarding pancreatitis, gallbladder disease and diabetic retinopathy.
Therefore, GLP-1 medicines should be started and adjusted under appropriate medical supervision.
Key Takeaway
GLP-1 medicines are not only injections.
Many GLP-1 medicines are injectable, but oral semaglutide is an important oral GLP-1 receptor agonist option.
The choice between an oral tablet and an injectable medicine depends on the individual’s diabetes, weight, medical history, treatment goals, preferences and the specific medication being considered.
If you are considering a GLP-1 medicine for diabetes, obesity or weight management, consult an endocrinologist before starting treatment.
About Dr. Moxit Shah
Dr. Moxit Shah, DM Endocrinologist in Ahmedabad, specializes in the management of diabetes, thyroid disorders, obesity and other endocrine conditions. GLP-1-based treatments can be considered as part of an individualized diabetes and weight-management plan when medically appropriate.
Vishuddha Endocrine Clinic, Ahmedabad
For appointments: +91 99799 92797
Frequently Asked Questions
1. Are GLP-1 medicines always injections?
No. Although many GLP-1 medicines are injectable, oral semaglutide is available as a tablet.
2. Is oral semaglutide a GLP-1 medicine?
Yes. Oral semaglutide is a GLP-1 receptor agonist.
3. Is oral semaglutide the same as Ozempic?
Both contain semaglutide, but Ozempic is an injectable formulation while Rybelsus is an oral formulation. Their dosing and administration are different.
4. Which is better—oral or injectable GLP-1 medicine?
There is no single answer for everyone. The appropriate choice depends on the patient’s medical condition, treatment goals, tolerability, preferences and the specific medicine.
5. Can I start a GLP-1 medicine on my own for weight loss?
It is best to consult a qualified doctor before starting these medicines because they require appropriate patient selection, dosing and monitoring.
